ERBB2 and breast carcinoma: The MTT assay showed that HER-2-positive breast cancer cells pre-treated with Compound C increased the effect of aspirin in terms of cell growth inhibition, which was highly unexpected (Figure 2C), although the result in MDA-MB-231 breast cancer cells was not significant with Compound C pretreatment (Supplementary Figure 1B).